Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in MD / Pediatrix Medical Group, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 197,681 shares of Pediatrix Medical Group, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -100.00 0
2025-08-14 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 197,681 0 0.00 2,837 -0.98 0.0081
2025-05-15 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 197,681 21,641 12.29 2,864 24.04 0.0094
2025-02-14 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 176,040 0 0.00 2,310 13.19 0.0070
2024-11-14 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 176,040 10,776 6.52 2,040 63.59 0.0060
2025-02-25 2024-06-30 13F/A-1 PEDIATRIX MEDICAL GROUP COM 58502B106 165,264 9,664 6.21 1,248 -20.06 0.0037
2024-08-14 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 165,264 9,664 1,248 0.0037
2024-05-15 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 155,600 -4,700 -2.93 1,561 4.70 0.0047
2024-07-16 2023-12-31 13F/A-1 PEDIATRIX MEDICAL GROUP COM 58502B106 160,300 0 0.00 1,491 -26.85 0.0048
2024-02-14 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 160,300 0 1,491 0.0029
2023-11-14 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 160,300 -2,200 -1.35 2,037 -11.78 0.0072
2023-08-14 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 162,500 -900 -0.55 2,309 -5.21 0.0077
2023-05-15 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 163,400 98,700 152.55 2,436 153.49 0.0084
2023-02-14 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 64,700 1,900 3.03 961 -7.24 0.0035
2023-02-14 2022-09-30 13F/A-1 Pediatrix Medical Group COM 58502B106 62,800 -2,600 -3.98 1,037 -24.60 0.0041
2022-11-14 2022-09-30 13F Pediatrix Medical Group COM 58502B106 62,800 -2,600 1,037 0.0041
2023-02-14 2022-06-30 13F/A-1 MEDNAX COM 58502B106 65,400 51,400 367.14 1,374 318.90 0.0051
2022-08-15 2022-06-30 13F MEDNAX COM 58502B106 65,400 51,400 1,374 0.0051
2023-02-14 2022-03-31 13F/A-1 MEDNAX COM 58502B106 14,000 14,000 329 0.0009
2022-05-13 2022-03-31 13F MEDNAX COM 58502B106 14,000 14,000 329 0.0009
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 0 -81,800 -100.00 0 -100.00
2021-11-15 2021-09-30 13F MEDNAX COM 58502B106 81,800 -70,600 -46.33 2,326 -49.38 0.0065
2021-08-13 2021-06-30 13F/A-1 MEDNAX COM 58502B106 152,400 -43,500 -22.21 4,595 -7.92 0.0130
2021-08-13 2021-06-30 13F MEDNAX COM 58502B106 152,400 -43,500 4,595 0.0078
2021-05-14 2021-03-31 13F MEDNAX COM 58502B106 195,900 900 0.46 4,990 4.28 0.0152
2021-02-12 2020-12-31 13F MEDNAX COM 58502B106 195,000 0 0.00 4,785 50.71 0.0150
2021-02-11 2020-09-30 13F/A-1 MEDNAX COM 58502B106 195,000 15,900 8.88 3,175 3.66 0.0115
2020-11-13 2020-09-30 13F MEDNAX COM 58502B106 195,000 15,900 3,175 6,337.8039
2021-02-12 2020-06-30 13F/A-1 MEDNAX COM 58502B106 179,100 179,100 3,063 0.0121
2020-08-14 2020-06-30 13F MEDNAX COM 58502B106 179,100 179,100 3,063 12,079.3875
2020-02-15 2019-12-31 13F MEDNAX COM 58502B106 0 -17,000 -100.00 0 -100.00
2021-02-12 2019-09-30 13F/A-1 MEDNAX COM 58502B106 17,000 17,000 385 0.0015
2019-11-14 2019-09-30 13F MEDNAX COM 58502B106 17,000 385 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.